ORPHA:289380
Myosclerosis
Also known as: Congenital myosclerosis, Löwenthal type
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
127
55.8th percentile
Trials
0
Interventional, condition-specific
Researchers
704
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
Myosclerosis is a rare, genetic, non-dystrophic characterized by early, diffuse, muscle and joint contractures that result in severe limitation of movement of axial, proximal, and distal joints, walking difficulties in early childhood and toe walking. Patients typically present thin, sclerotic muscles with a woody consistency, mild girdle and proximal limb weakness with moderate distal weakness and scoliosis. Muscle biopsy shows partial collagen VI deficiency at the myofiber basement membrane and absent collagen VI around most endomysial/perimysial capillaries.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009714
- MeSH:C564968
- OMIM:255600
- UMLS:C1850671
Additional Mondo synonyms (3)
congenital myosclerosis, LC6wenthal type · congenital myosclerosis, Löwenthal type · myosclerosis, congenital
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
127 matched papers (57 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
127
127 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
127 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
57 in the last 10 years · medium confidence · 55.8th percentile (publications denominator)
Phrase hits: 127 · MeSH hits: 0
Who's working on it?
704
Distinct author names in 127 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Merlini L21 papers · 2025
SC Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute, Bologna 40136, Italy.
Papers in Europe PMC - 02Bonaldo P19 papers · 2025
Department of Molecular Medicine, University of Padova, Padova 35128, Italy.
Papers in Europe PMC - 03Sabatelli P17 papers · 2025
Institute of Molecular Genetics, CNR-National Research Council of Italy, Bologna 40129, Italy.
Papers in Europe PMC - 04Faldini C12 papers · 2025
j Department of Orthopedics , University of Bologna , Bologna , Italy.
Papers in Europe PMC - 05Gualandi F11 papers · 2025
Medical Genetics Unit, Department of Medical Sciences, University of Ferrara, Ferrara 44121, Italy.
Papers in Europe PMC - 06Bernardi P9 papers · 2021
Department of Biomedical Science, University of Padova, Padova 35128, Italy.
Papers in Europe PMC - 07Bönnemann CG8 papers · 2025
Division of Neurology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104.
Papers in Europe PMC - 08Maraldi NM8 papers · 2016
b Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute , Bologna , Italy.
Papers in Europe PMC - 09Squarzoni S8 papers · 2024
Institute of Molecular Genetics-National Research Council, Unit of Bologna, 40136 Bologna, Italy.
Papers in Europe PMC - 10Grumati P7 papers · 2018
Department of Histology, Microbiology and Medical Biotechnology, University of Padova, Padova, Italy.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
medium confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Myosclerosis" OR "Congenital myosclerosis, Löwenthal type" OR "congenital myosclerosis, LC6wenthal type" OR "myosclerosis, congenital"
MeSH descriptor terms unioned into the query: Myosclerosis, Autosomal Recessive
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Myosclerosis" OR "Congenital myosclerosis, Löwenthal type" OR "congenital myosclerosis, LC6wenthal type" OR "myosclerosis, congenital" OR "Myosclerosis, Autosomal Recessive"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T12:12:46.921Z